MAPT and Parkinson disease: Several studies observed that lower baseline concentrations of Aβ42 in the CSF were associated with worse cognition and predicted cognitive decline in people with PD, and transition to PDD [21,103,104,105], while CSF total Tau and phosphorylated Tau showed inconsistent findings [104,106,107,108].